A donor baby is a child conceived specifically to provide life-saving biological material, usually stem cells, to an older sibling with a serious genetic or blood disorder. The more common medical term is “savior sibling.” Parents use in vitro fertilization (IVF) combined with genetic testing to select an embryo that is both free of the family’s genetic disease and a tissue match for the sick child. Once the baby is born, stem cells collected from the umbilical cord blood or, later, from bone marrow can be transplanted to treat the ill sibling.
How the Process Works
Creating a donor baby involves several precise steps. First, eggs are retrieved from the mother and fertilized in a lab through standard IVF. The resulting embryos are then screened using a technique called preimplantation genetic diagnosis, or PGD. This screening accomplishes two things at once: it identifies which embryos are free of the genetic disease that affects the older child, and it checks which of those healthy embryos are a tissue match. Tissue matching looks at a set of immune system markers called HLA types, which need to align closely between donor and recipient for a transplant to succeed.
Only embryos that pass both tests are candidates for transfer to the mother’s uterus. This narrows the odds considerably. In a review of 327 IVF cycles attempted by 171 couples between 2003 and 2010, the pregnancy rate was about 35 percent, and a total of 59 tissue-matched children were born. Some couples went through as many as nine cycles before achieving a successful pregnancy.
After birth, the most immediate source of donor cells is the umbilical cord blood, which is rich in stem cells and can be collected painlessly. If cord blood alone isn’t sufficient, a bone marrow donation from the child may follow later in life.
Conditions That Lead Families to This Option
Families typically pursue a donor baby when their existing child has a life-threatening genetic disease and no suitable adult bone marrow donor can be found through registries. The conditions treated this way tend to be rare, severe, and progressive.
- Fanconi anemia causes bone marrow failure, skeletal abnormalities, and a high risk of leukemia and other cancers.
- Thalassemia (severe forms) requires constant medication and regular blood transfusions throughout life.
- Diamond-Blackfan anemia is associated with congenital malformations including heart defects, cleft palate, and limb abnormalities.
All three carry bleak long-term prognoses without a stem cell transplant from a well-matched donor. A sibling who is a perfect or near-perfect HLA match offers a significantly better chance of transplant success than an unrelated donor from a registry.
The First Donor Baby
The concept moved from theory to reality on August 29, 2000, when Adam Nash was born in Colorado. His older sister Molly had Fanconi anemia, and no matching donor could be found. Her parents worked with fertility specialists to conceive Adam through IVF with both genetic disease screening and tissue typing. Weeks after his birth, Molly received a stem cell transplant from his umbilical cord blood. The transplant worked. As of 2017, both Adam and Molly were healthy young adults.
Other prominent cases followed. The Whitaker family in Britain traveled to Chicago in 2002 to create a matched donor for their son, who had Diamond-Blackfan anemia, after being denied permission in the UK. The Fletcher family produced the first British donor baby in 2005, also for Diamond-Blackfan anemia.
Legal Status Varies Widely
How donor babies are regulated depends almost entirely on where you live. In the United States, there are no laws prohibiting the use of genetic testing for tissue matching and embryo selection, and no clear professional guidelines governing the practice. Doctors are free to perform the procedures at their discretion. Israel and Turkey take a similarly unregulated approach.
The United Kingdom is far more restrictive. The Human Fertilisation and Embryology Authority (HFEA) requires case-by-case approval, and noncompliance carries criminal penalties. As of 2009, the HFEA had granted just twelve licenses for savior sibling creation. Every decision involving the donor child must meet what the authority calls “the best interest test,” meaning the welfare of the new child is weighed alongside the potential benefit to the sick sibling.
Ethical Concerns
The central ethical tension is straightforward: is it acceptable to bring a child into the world partly as a means to save another? Supporters argue the child is wanted, loved, and would not exist at all without the medical need. Critics worry the child’s autonomy is compromised before they’re even born, and that their value within the family may become tied to their usefulness as a donor.
The American Academy of Pediatrics has outlined specific conditions under which it considers bone marrow donation by a minor to be ethical. These include confirming that no suitable adult donors exist, that a strong positive relationship exists between donor and recipient, that the transplant has a reasonable chance of benefiting the recipient, that risks to the donor are minimized, and that appropriate consent is obtained. These criteria apply to all child donors, not just savior siblings, but they carry particular weight in these cases because the child was conceived with donation in mind.
There’s also the question of what happens when the cord blood transplant doesn’t work. The United States has no registry tracking how many donor children go on to undergo more invasive bone marrow harvesting after an initial transplant fails.
Psychological Effects on the Donor Child
Research on siblings who donate stem cells or bone marrow reveals a complicated emotional picture. Donor siblings report significantly more anxiety and lower self-esteem than siblings who were not donors. Roughly one-third of all siblings in transplant families experience moderate to severe post-traumatic stress symptoms, and donors are at elevated risk for depression, behavioral problems, and feelings of guilt and resentment.
The outcomes aren’t uniformly negative. Many donors describe a deep sense of purpose and closeness to their sibling. But the psychological toll tends to be worse under specific circumstances: when the child felt uninformed about the donation process or the possibility that their sibling might die, when they lacked support from family or medical staff, and when they bottled up their feelings rather than expressing them. Siblings in families where the transplant ultimately failed reported greater guilt and were less likely to experience any positive psychological effects from the experience.
These findings come from studies of sibling donors generally, not exclusively savior siblings. But the emotional dynamics are amplified for a child who may eventually learn they were conceived, in part, to serve as a donor. Families who pursue this path are generally encouraged to provide age-appropriate honesty, psychological support, and a family environment where the donor child’s identity extends well beyond their role in their sibling’s treatment.